Urokinase receptor: A molecular organizer in cellular communication

Current Opinion in Cell Biology

Volumn 12, Issue 5, 2000, Pages 621-628

  Preissner, Klaus T ^a   Kanse, Sandip M ^a   May, Andreas E ^b  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN; INTEGRIN; UROKINASE RECEPTOR;

ANGIOGENESIS; CARCINOGENESIS; CELL COMMUNICATION; CELL FUNCTION; CELL INVASION; CELL MIGRATION; CHEMOTAXIS; ENDOCYTOSIS; INFLAMMATION; LEUKOCYTE ADHERENCE; LIGAND BINDING; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; WOUND HEALING;

EID: 0033818463     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(00)00141-1     Document Type: Review

References (76)

1. The plasminogen activation system in tumor growth, invasion, and metastasis
2. Plasminogen activators, integrins, and the co-ordinated regulation of cell adhesion and migration
3. Proteolysis and cell migration: Creating a path?
4. Role of vitronectin and its receptors in haemostasis and vascular remodeling
5. The urokinase receptor
6. The cell biology of the plasminogen system
7. Recycling of the urokinase receptor upon internalization of the uPA: Serpin complexes
8. α2-macroglobulin receptor/LDL receptor-related protein (LRP)-dependent internalization of the urokinase receptor
9. Development and disease in proteinase-deficient mice: Role of the plasminogen, matrix metalloproteinase and coagulation system
10. Haemostatic factors and inflammatory disease
11. Receptor-independent role of urokinase-type plasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vascular wound healing in mice
12. Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator
13. Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans
14. Urokinase-type plasminogen activator-deficient mice are predisposed to staphyloccocal botryomycosis, pleuritis, and effacement of lymphoid follicles
15. Plasminogen deficiency differentially affects recruitment of inflammatory cell populations in mice
16. Urokinase receptor (CD87) regulates leukocyte recruitment via β2-integrins in vivo
17. Nonproteolytic role for the urolinase receptor in cellular migration in vivo
18. uPA, uPAR, PAI-1: Key intersection of proteolytic, adhesive and chemotactic highways?
19. Mechanisms of signalling through urokinase receptor and the cellular response
20. Increased expression of u-PA and u-PAR on monocytes by LDL and Lp(a) lipoproteins-consequences for plasmin generation and monocyte adhesion
21. Hypoxia stimulates urokinase receptor expression through a heine protein-dependent pathway
22. In vivo paracrine interaction between urokinase and its receptor: Effect on tumor cell invasion
23. Clinical impact of the plasminogen activation system in tumor invasion and metastatis: Prognostic relevance and target for therapy
24. Differential expression of genes by tumor cells of a low or a high malignancy phenotype: The case of murine and human Ly-6 proteins
25. Caveolae, DIGS and the dynamics of sphingolipid-cholesterol microdomains
26. GPI-microdomains: A role in signalling via immunoreceptors
27. Role of urokinase receptor and caveolin in regulation of integrin signaling
28. Regulation of integrin function by the urokinase receptor
29. Identification of a urokinase receptor-integrin interaction site - Promiscuous regulator of integrin function
30. Domain interplay in the urokinase receptor. Requirement for the third domain in high affinity ligand binding and demonstration of ligand contact sites in distinct receptor domains
31. Identification of the urokinase receptor as an adhesion receptor for vitronectin
32. The urokinase receptor is a major vitronectin binding protein on endothelial cells
33. The serpin PAI-1 inhibits cell migration by blocking integrin avb3 binding to vitronectin
34. Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation
35. Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor
36. Opposing effects of low and high molecular weight kininogens on cell adhesion
37. Different mechanisms define the antiadhesive function of high molecular weight kininogen in integrin- and urokinase receptor-dependent interactions
38. The intact urokinase receptor is required for efficient vitronectin binding: Receptor cleavage prevents ligand interaction
39. The level of urokinase-type plasminogen activator receptor is increased in serum of ovarian cancer patients
40. Impaired migration in vitro of neutrophils from patients with paroxysmal nocturnal haemoglobinuria
41. Vitronectin concentrates proteolytic activity on the cell surface and extracellular matrix by trapping soluble urokinase receptor-urokinase complexes
42. Vitronectin binding to urokinase receptor in human breast cancer
43. Urokinase receptor (uPAR, CD87) is a platelet receptor important for kinetics and TNF-induced endothelial adhesion in mice
44. The urokinase receptor (CD87) is expressed in cells of the megakaryoblastic lineage
45. Novel interactions between urokinase and its receptor
46. Molecular crosstalk between adhesion receptors and proteolytic cascades in vascular remodeling
47. Requirement of receptor-bound urokinase-type plasminogen activator for integrin αvβ5-directed cell migration
48. Integrin αvβ3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis
49. Co-operative effect of TNF-α, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity
50. Molecular mechanisms of zinc-dependent leukocyte adhesion involving the urokinase receptor and β2-integrins
51. Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization
52. Kininogens are antithrombotic proteins in vivo
53. Vitronectin inhibits the thrombotic response to arterial injury in mice
54. Plasminogen activator inhibitor-1 and vitronectin promote vascular thrombosis in mice
55. The urokinase receptor. A cell surface, regulated chemokine
56. A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity
57. Src-dependence and pertussis-toxin sensitivity of urokinase receptor-dependent chemotaxis and cytoskeleton reorganization in rat smooth muscle cells
58. Urokinase receptor-dependent and -independent p56/59(hck) activation state is a molecular switch between myelomonocytic cell motility and adherence
59. Protein kinase C-dependent in vivo phosphorylation of prourokinase leads to the formation of a receptor competitive antagonist
60. The chemotactic action of urokinase on smooth muscle cells is dependent on its kringle comain; characterization of interactions and contribution to chemotaxis
61. The tetraspanin superfamily: Molecular facilitators
62. Integrins as promiscuous signal transduction devices
63. Urokinase plasminogen activator receptor, β2-integrins, and scr-kinases within a single receptor complex of human monocytes
64. Proximity oscillations of complement type 4 (αXβ2) and urokinase receptors on migrating neutrophils
65. Mac-1 (CD11b/CD18) and the urokinase receptor (CD87) form a functional unit on monocytic cells
66. The urokinase receptor (CD87) facilitates CD11B/CD18-mediated adhesion of human monocytes
67. VLA-4 (α4β1) engagement defines a novel activation pathway for β2 integrin-dependent leukocyte adhesion involving the urokinase receptor
68. Integrin-dependent induction of functional urokinase receptors in primary T tymphocytes
69. Neutrophil emigration in the skin, lungs, and peritoneum: Different requirements for CD11/CD18 revealed by CD18-deficient mice
70. A urokinase receptor-associated protein with specific collagen binding properties
71. A role for caveolin and the urokinase receptor in integrin-mediated adhesion and signaling
72. A requirement for caveolin-1 and associated kinase fyn in integrin signaling and anchorage-dependent cell growth
73. Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling
74. Myosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner
75. Mannose 6-phosphate/insulin-like growth factor II receptor targets the urokinase receptor to lysosomes via a novel binding interaction
76. M6P/IGFII-receptor complexes urokinase receptor and plasminogen for activation of transforming growth factor-β1